Altitude exposure reduces the partial pressure of oxygen in inspired air, triggering a cascade of physiological responses that let the body cope short term but can fail if ascent is too rapid. Research on high-altitude adaptation by Cynthia M. Beall, Case Western Reserve University, explains how indigenous populations show genetic and physiological differences that develop over generations, while recreational trekkers must rely on short-term acclimatization strategies. Individual response varies widely, and understanding causes and consequences helps reduce risk.
Understanding altitude physiology
The core cause of altitude illness is hypobaric hypoxia: lower barometric pressure means less oxygen reaches the lungs and bloodstream. Early responses include increased breathing, faster heart rate, and fluid shifts that can produce headache, nausea, or fatigue—hallmarks of acute mountain sickness (AMS). If hypoxia worsens, fluid can accumulate in the brain or lungs, causing high-altitude cerebral edema or high-altitude pulmonary edema, both life-threatening. The definitive immediate treatment for severe illness is descent, often combined with supplemental oxygen or a portable hyperbaric chamber when descent is delayed. Populations like Tibetans and Andeans show adaptations that reduce risk, but those benefits are not available to visitors.
Practical acclimatization strategies
Safe acclimatization depends on controlled ascent, symptom monitoring, modest medications when appropriate, and respect for local expertise. Follow gradual ascent: above about 3,000 meters, increase sleeping elevation by no more than 300 to 500 meters per day and build in a rest day for every 600 to 900 meters of gain. Use the principle "climb high, sleep low" when terrain permits—ascend during the day but return to a lower sleeping elevation to promote adaptation. Stay well hydrated, eat sufficient calories, avoid alcohol or sedatives that can blunt breathing response, and limit heavy exertion during initial days.
Guidance from Andrew M. Luks, Wilderness Medical Society, supports the use of acetazolamide for prophylaxis in at-risk trekkers; the commonly recommended regimen is 125 mg twice daily starting either 24 hours before ascent or at the beginning of ascent, with adjustments as advised by a clinician. Acetazolamide can speed acclimatization by stimulating ventilation, but it is contra-indicated in people with sulfa allergies and may cause paresthesias or taste changes. Pharmacologic measures supplement but do not replace gradual ascent and monitoring.
Monitor for early warning signs and use objective checks if available. Mild headache, poor sleep, dizziness, or reduced appetite merit slowing ascent and reassessment. If symptoms progress—especially confusion, ataxia, persistent cough, or breathlessness at rest—initiate immediate descent and seek urgent care. Portable oxygen and inflatable hyperbaric bags provide temporary stabilization when evacuation is delayed.
Respect local routes, weather patterns, and the experience of guides and porters; cultural knowledge often includes pacing and rest practices tuned to specific ranges such as the Himalaya or Andes. Environmental and territorial realities—trail crowding, limited evacuation resources, and seasonal weather windows—affect safe acclimatization planning. Combining scientific guidance, such as Wilderness Medical Society recommendations, with local expertise and conservative decision-making gives the best chance of a safe, enjoyable trek.